ATE190625T1 - Antagonisten gegen den thrombinrezeptor - Google Patents

Antagonisten gegen den thrombinrezeptor

Info

Publication number
ATE190625T1
ATE190625T1 AT93917028T AT93917028T ATE190625T1 AT E190625 T1 ATE190625 T1 AT E190625T1 AT 93917028 T AT93917028 T AT 93917028T AT 93917028 T AT93917028 T AT 93917028T AT E190625 T1 ATE190625 T1 AT E190625T1
Authority
AT
Austria
Prior art keywords
thrombin receptor
hydrophobic radical
linkages
formula
image
Prior art date
Application number
AT93917028T
Other languages
English (en)
Inventor
Robert M Scarborough
Original Assignee
Cor Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cor Therapeutics Inc filed Critical Cor Therapeutics Inc
Application granted granted Critical
Publication of ATE190625T1 publication Critical patent/ATE190625T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT93917028T 1992-07-30 1993-07-08 Antagonisten gegen den thrombinrezeptor ATE190625T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92234092A 1992-07-30 1992-07-30
US8078893A 1993-06-28 1993-06-28
PCT/US1993/006428 WO1994003479A1 (en) 1992-07-30 1993-07-08 Thrombin receptor antagonists

Publications (1)

Publication Number Publication Date
ATE190625T1 true ATE190625T1 (de) 2000-04-15

Family

ID=26763931

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93917028T ATE190625T1 (de) 1992-07-30 1993-07-08 Antagonisten gegen den thrombinrezeptor

Country Status (10)

Country Link
US (1) US5866681A (de)
EP (1) EP0656008B1 (de)
JP (1) JP2675438B2 (de)
AT (1) ATE190625T1 (de)
AU (1) AU669922B2 (de)
CA (1) CA2140543C (de)
DE (1) DE69328104T2 (de)
IL (1) IL106197A (de)
SG (1) SG49772A1 (de)
WO (1) WO1994003479A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063847A (en) 1997-11-25 2000-05-16 Schering Corporation Thrombin receptor antagonists
JP3449620B2 (ja) * 1997-11-25 2003-09-22 シェーリング コーポレイション トロンビンレセプターアンタゴニスト
US6017890A (en) * 1998-02-19 2000-01-25 Ortho-Mcneil Pharmaceutical, Inc. Azole peptidomimetics as thrombin receptor antagonists
ES2183515T3 (es) * 1998-02-19 2003-03-16 Ortho Mcneil Pharm Inc Peptidomimeticos de azol utilizados como antagonistas del receptor de la trombina.
GB2356198A (en) 1999-10-29 2001-05-16 Merck & Co Inc Isoxazole thrombin receptor antagonists
US6515023B2 (en) 2000-01-31 2003-02-04 Merck & Co., Inc. Thrombin receptor antagonists
US6403612B2 (en) 2000-01-31 2002-06-11 Merck & Co., Inc. Thrombin receptor antagonists
US7235567B2 (en) 2000-06-15 2007-06-26 Schering Corporation Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
MY130642A (en) 2000-06-15 2007-07-31 Schering Corp Nor-seco himbacine derivatives useful as thrombin receptor antagonists
EP1343751A2 (de) 2000-12-20 2003-09-17 Bristol-Myers Squibb Company Cyclische derivate als modulatoren der chemokinrezeptoraktivität
AU2002241724A1 (en) 2000-12-20 2002-07-01 Bristol-Myers Squibb Company Diamines as modulators of chemokine receptor activity
US20040096443A1 (en) * 2002-03-08 2004-05-20 Traynelis Stephen Francis Treatment of neurodegenerative diseases and conditions using par1 antagonists
JP4307260B2 (ja) 2001-10-18 2009-08-05 シェーリング コーポレイション トロンビンレセプタアンタゴニストとしてのヒンバシン類似物
IL164376A0 (en) * 2002-04-03 2005-12-18 Applied Research Systems Ox4or binding agents, their preparation and pharmaceutical compositions containing them
NZ575139A (en) 2002-04-16 2010-08-27 Schering Corp Tricyclic thrombin receptor antagonists
US7074765B2 (en) 2003-05-01 2006-07-11 The Regents Of The University Of Michigan Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
ATE406366T1 (de) * 2004-05-28 2008-09-15 Schering Corp Gehinderte himbacinanaloga als thrombinrezeptorantagonisten
EP2075250B1 (de) 2004-10-08 2015-03-04 Merck Sharp & Dohme Corp. Thrombinrezeptorantagonisten
JP2008534604A (ja) 2005-03-31 2008-08-28 シェーリング コーポレイション スピロ環式トロンビンレセプターアンタゴニスト
KR20080104352A (ko) 2006-03-29 2008-12-02 쉐링 코포레이션 트롬빈 수용체 길항제로서 유용한 모노사이클릭 및 비사이클릭 힘바신 유도체
JP2009533450A (ja) 2006-04-13 2009-09-17 シェーリング コーポレイション 縮合環トロンビンレセプターアンタゴニスト
WO2008005262A1 (en) 2006-06-29 2008-01-10 Schering Corporation Substituted bicyclic and tricyclic thrombin receptor antagonists
KR20090074219A (ko) 2006-10-04 2009-07-06 쉐링 코포레이션 트롬빈 수용체 길항제로서의 비사이클릭 및 트리사이클릭 유도체
MX2009010268A (es) * 2007-03-23 2009-11-09 Schering Corp Reduccion de eventos adversos despues de intervencion percutanea mediante el uso de un antagonista del receptor de trombina.
US20090022729A1 (en) * 2007-04-13 2009-01-22 Nigel Mackman Methods and compositions for treating cardiac dysfunctions
JP5504259B2 (ja) 2008-05-19 2014-05-28 メルク・シャープ・アンド・ドーム・コーポレーション 第ｉｘａ因子阻害剤としての複素環式化合物
WO2011017296A1 (en) 2009-08-04 2011-02-10 Schering Corporation 4, 5, 6-trisubstituted pyrimidine derivatives as factor ixa inhibitors
EP2335717A1 (de) 2009-11-16 2011-06-22 Institut National De La Recherche Agronomique PAR-1-Antagonisten zur Verwendung bei der Behandlung oder Prävention von Influenzavirus-Typ-A-Infektionen
EP2822557B1 (de) 2012-03-06 2017-08-23 Merck Sharp & Dohme Corp. Herstellung und verwendung bicyclischer himbacinderivate als par-rezeptor-antagonisten
WO2015026686A1 (en) 2013-08-22 2015-02-26 Merck Sharp & Dohme Corp. 3'-pyridyl substituted- 6,6-difluoro bicyclic himbacine derivatives
EP3035929B1 (de) 2013-08-22 2024-07-03 Merck Sharp & Dohme LLC 7a-amid-substituierte bicyclische 6,6-difluorhimbacinderivate
EP3035930A4 (de) 2013-08-22 2017-03-08 Merck Sharp & Dohme Corp. 7a-heterocyclus-substituierte 6,6-difluor-bicyclus-himbacinderivate
EP3131897B8 (de) 2014-04-16 2022-08-03 Merck Sharp & Dohme LLC Faktor-ixa-hemmer
CA3189771A1 (en) 2020-07-22 2022-01-27 Janssen Pharmaceutica Nv Compounds useful as factor xia inhibitors
US11919881B2 (en) 2021-03-18 2024-03-05 Janssen Pharmaceutica Nv Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitors
US11814364B2 (en) 2021-03-18 2023-11-14 Janssen Pharmaceutica Nv Pyridine N-oxide derivatives useful as factor XIa inhibitors
US11845748B2 (en) 2021-03-18 2023-12-19 Janssen Pharmaceutica Nv Bicyclic pyridine N-oxide derivatives useful as a factor XIa inhibitors
US11897880B2 (en) 2021-04-30 2024-02-13 Janssen Pharmaceutica Nv 7,8-dihydrobenzo[e]pyrido[3,4-c]azocine-2,5(3H,6H)-dione derivatives useful as a factor XIa inhibitors
US11958856B2 (en) 2021-07-22 2024-04-16 Janssen Pharmaceutica Nv Substituted 1,2,3,8,9,9a-hexahydro-5H-pyrrolo[1,2-a]azepin-5-ones as factor XIa inhibitors
US12286429B2 (en) 2021-07-22 2025-04-29 Janssen Pharmaceutica Nv 5-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide derivatives useful as a factor XIa inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2589720A1 (fr) * 1985-11-14 1987-05-15 Aubaniac Jean Ensemble prothetique pour l'articulation du genou
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US5256766A (en) * 1991-02-19 1993-10-26 The Regents Of The University Of California Recombinant thrombin receptor and related pharmaceuticals
JPH07507995A (ja) * 1992-03-02 1995-09-07 バイオジェン，インコーポレイテッド トロンビンレセプターアンタゴニスト

Also Published As

Publication number Publication date
SG49772A1 (en) 1998-06-15
JPH07506115A (ja) 1995-07-06
US5866681A (en) 1999-02-02
DE69328104D1 (de) 2000-04-20
EP0656008A1 (de) 1995-06-07
AU669922B2 (en) 1996-06-27
CA2140543C (en) 2001-04-10
IL106197A (en) 1999-11-30
EP0656008B1 (de) 2000-03-15
DE69328104T2 (de) 2000-12-21
JP2675438B2 (ja) 1997-11-12
CA2140543A1 (en) 1994-02-17
IL106197A0 (en) 1994-05-30
WO1994003479A1 (en) 1994-02-17
AU4668593A (en) 1994-03-03

Similar Documents

Publication Publication Date Title
ATE190625T1 (de) Antagonisten gegen den thrombinrezeptor
ATE37375T1 (de) Phosphonyl-hydroxyacyl-aminosaeure-derivate und ihre verwendung als antihypertensiva.
DE69904736D1 (de) Dithiocarbamyl-derivate geeignet als schmiermitteladditive
DE60132171D1 (de) Tocopherole, tocotrienole, andere chrome und seitenketten-derivate und ihre verwendung
TR199902194T2 (xx) +p38 protein kinaz inhibit�rleri olarak ikameli azot ihtiva eden heterosikler.
ATE175198T1 (de) N-acylierte trizyklische azaheteroringe verwendbar als vasopressin-antagonisten
ES2162676T3 (es) Derivados de fenileno sustituidos en meta y su uso como antagonistas o inhibidores de integrina alfav,beta3.
ATE227277T1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
NO952366D0 (no) Dolostatin-analog
DK0773956T3 (da) Renset form for streptograminer, fremstilling deraf og farmaceutiske sammensætninger, der indeholder denne
DE69712084D1 (de) Aminothiazole derivate, ihre herstellung und sie enthaltenden pharmazeutischen zusammensetzungen
ES2132882T3 (es) Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina 1.
NO953270L (no) Fibrinogenreceptorantagonister
FI955118A0 (fi) Herbisidiset substituoidut 1-fenyyli- tai 1-pyridinyyli-bentsotriatsolit
DE68905809D1 (de) N-substituierte carbamate und ihre verwendung als zusaetze fuer kraftstoffe.
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
ES2129123T3 (es) Nuevo derivado de bisoxadiazolidina.
TR200101493T2 (tr) Eletriptan hidrobromid monohidrat
IE45607L (en) Psychopharmacologically active peptides
ES2122245T3 (es) Derivados de piperazina como ligandos 5-ht1a.
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
DK0461574T3 (da) Lægemidler indeholdende 3,7-diazabicyclo(3,3,1)-nonanforbindelser
BR9508979A (pt) Carboxamidas bicíclicas como antagonistas de 5-ht1a
ATE218138T1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
MXPA02001861A (es) Nuevos inhbidores de la integrina alfav beta3.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee